Milestone Phase II Clinical Study Demonstrates Niagen®, Patented Nicotinamide Riboside (NR), Improves Functional Mobility for Individuals with Peripheral Artery Disease (PAD)
NR improved the six-minute walking distance and treadmill walking time for those with PAD Contacts ChromaDex Media Contact: Kendall Knysch,...